Interaction between cytotoxic T lymphocyte-asso-ciated antigen-4 (CTLA4, CD152) and B7 molecules (B7-1 and B7-2) is of importance in the cellular events of lymphocyte, including antigen-specific T-cell activation and induction of autoreactive T-cell. We describe here the first introduction of a murine soluble CTLA4 gene, CTLA4Ig, to Mm1 cells, a macrophagic cell line. CTLA4Ig was successfully expressed on Mm1 cells and the expressed CTLA4Ig was found to be functionally active in their binding to B7 molecules by flow cytometry and immunofl-uorescence studies. The biological activity of CTLA4Ig from the transfected Mm1 cells was studied and showed inhibitory activity on mixed lymphocyte culture. A high CTLA4Ig producing macrophagic cell line was obtained. As Mm1 cells were regarded as difficult for gene transfection and there had so far been no report on expression of CTLA4Ig gene on Mm1 cells, these results suggested that the CTLA4Ig ex- 
INTRODUCTION
It is recently reported that B7 and CD28/CTLA4 pathway plays a critical role in the activation of T-cell [1] [2] [3] , as well as in the onset of autoimmunity both in human and murine model of autoimmunity [4] [5] [6] [7] . B7 molecules are expressed on a variety of cell types, including dentritic cells, B cells, T-cells and macrophages [8] [9] [10] [11] . CTLA4Ig, a soluble form of CTLA4, could block B7 and CD28/CTLA4 pathway and results in the inhibitation of Tcell activation and autoimmune response [12] [13] [14] [15] [16] [17] [18] [19] .
The macrophagic Mm1 cell line was regarded as a good model for studying macrophage differentiation and cellular functional expression [20] [21] [22] [23] . Mm1 cells were derived from M1 cells that were established from a spontaneous myeloid leukemia of SL strain mice [24] , [25] . Previous studies revealed that Mm1 cells possessed some, but not all, mature macrophage phenotypes and immunological functions, for example, they have Fc receptor and phagocytic capacity, but lack accessory cell activity and Ia antigen [26] , [27] . The involvement of tumor necrosis factor and colony stimulating factor in the differentiation of macrophage were also investigated recently [23] , [28] , [29] .
Like other macrophage lines or primary macrophages [30] , Mm1 cells were regarded to be difficult for transfection and few attempts have been made for gene transfection in Mm1 cells. To study whether Mm1 cells can be successfully transfected by CTLA4Ig gene, we made a trial to transfect a murine CTLA4Ig gene into Mm1 cells. The expression of CTLA4Ig from transfected Mm1 cells was characterized in this study. We thus showed that CTLA4Ig gene was successfully transfected into Mm1 cells and expressed positively and stably. Moreover, we confirmed the biological activities of CTLA4Ig produced by the transfected Mm1 cells. Our study resulted in the establishment of a new macrophage line and indicated possible approach to further genetic engineering studies of Mm1 cells.
IgG2aFc, and pMKITneo vector that was kindly provided by K. Maruyama (Tokyo Medical and Dental University). Stable expression of CTLA4Ig DNA in Mm1 cells was performed by using Gene Pulser (Bio-Rad Laboratories, Hercules, CA) according to the method of Wang et al. [33] with slight modifications. Briefly, the constructed CTLA4Ig plasmid was purified by centrifugation in cesium chloride and was linearized with restriction enzyme Sma I (Wako Pure Chemical Industries, Japan) digestion. 10 μg DNA in 10 μl Ca 2+ and Mg 2+ free phosphate-buffered saline (PBS) was mixed with 3 10 6 Mm1 cells suspended in 0.2 ml culture medium. The DNA and the cells were allowed to sit for 10 min at room temperature in a chamber (Bio-Rad) and then subjected to an electric pulse at 300 V and 960 μF. Cells were allowed to sit for 10 min further at 0 O C before adding 10 ml culture medium. The cells were then seeded in 96-well-microplate (Nunc, Roskilde, Denmark) with a cell density of 3 10 4 cells per well in culture medium containing 0. 5 mg/ml neomycin G418 (Boehringer Mannheim Biochemica, Germany) for selection of positive clones. Cells were grown for 10 days until colonies appeared without change of culture medium. Culture supernatant from the microplate was screened by an enzyme-linked immunosorbent assay (ELISA, described later) for CTLA4Ig, then the positive colonies were subsequently cloned twice by limiting dilution to obtain high CTLA4Ig producing clones.
Sandwich ELISA, SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting Sandwich ELISA for CTLA4Ig was performed as follows. Samples (0.1 ml) were plated to wells of an ELISA plate (Nunc, MaxiSorp) coated with hamster anti-mouse CTLA4 monoclonal antibody (mAb, clone 4F-10, PharMingen, San Diego, CA), and incubated at 37 o C for 1 h, and the plate was washed three times with PBS containing 0.5% Tween-20 (T-PBS). Then, 0.1 ml of horseradish peroxidase(HRP)-labeled polyclonal rabbit anti-mouse IgG2a (γ 2a chain) antibody (1:500 dilution, Organon Teknika Corp., Durham, NC) was added and incubated at 37 o C for 1 h. After washing, substrate solution containing O-phenylenediamine was added and colourimetric reaction was terminated by 1N phosphoric acid. Spectraphotometric measurement was carried out with a microplate reader (Bio-Rad) at 490 nm. The CTLA4Ig amounts were calibrated with a standard curve of CTLA4Ig protein that was purified from culture supernatant of a stably murine CTLA4Ig transfected Chinese hamster ovary (CHO) cell line established in our preliminary studies (data not reported, CHO was from Riken Cell Bank) with an affinity column of protein A-Sepharose (Pharmacia Sweden).
SDS-PAGE was done according to the method of Laemmli [34] . Mouse IgG1 and IgG2a were used as control proteins. Samples were run under both reducing (+2-Mercaptoethanol, 2ME) and non-reducing (-2ME) conditions. After the SDS-PAGE, the proteins were stained by Coomassie Brilliant Blue, or blotted onto nitrocellulose membranes (pore size, 0.2 μm). The membranes were soaked in 5% skim milk (in PBS) and then treated either with HRP-conjugated goat anti-mouse Ig or rabbit anti-mouse IgG2a (γ 2a chain) antibody alone, or with 1:1000 dilution of the primary antibody (anti-mouse CTLA4 mAb, clone 4F-10) and 1:2000 dilution of the second antibody (HRP-conjugated goat anti-hamster IgG, Southern Biotechnology Associates, Inc., Birmingham, AL). After washing, the membranes were treated with the substrate (3,3 , 5,5 -tetramethylbenzidine, TMB, Kirkegaar and Perry Laboratories Inc., Gaithersburg, MD) until bluish purple color developed.
Flow cytometry and immunofluorescence 
RESULTS AND DISCUSSION

Successful expression of CTLA4Ig gene on Mm1 cells
CTLA4Ig is a soluble fusion protein consisting of extracellular domain of CTLA4 and IgG Fc region. The plasmid PM/CTLA4Ig used in this study encodes the extracellular portion of mouse CTLA4 and mouse IgG2aFc. In the initial attempts to transfect the plasmid into the Mm1 cells by using electroporation, variations on setting the power supplies and capacitance as well as the cell number and DNA concentration have been done. Alternatively, the temperature was also changed. We found that the optimal condition for Mm1 cell transfection was 300 V and 960 μF (the time constant was 30 msec) performed at room temperature.
After the electroporation, colonies that showed resistance to G418 were screened by sandwich ELISA for mouse CTLA4Ig as described in materials and methods. A high CTLA4Ig producing clone, E522.7.50, was obtained. To confirm molecular weight of the protein released from E522.7.50, the culture supernatant was passed over a protein ASepharose column and an eluate was subjected to electrophoresis. A single protein band consisted with molecular weight of 110,000 daltons without reduction was observed (Fig  1, lanes 3, 6, 9 and 12 ). Western blotting also showed a single band at a molecular weight of 55,000 daltons with reduction (Fig 1, lane 15) , indicating that the purified protein was a formation of homodimer. Moreover, Western blotting analysis showed that anti-mouse IgG2a (γ2a chain) antibody and anti-mouse CTLA4 mAb bound to the purified proteins specifically (Fig 1, lanes 9, 12 and 15) . These results confirmed the isotype specificity of the fusion protein of CTLA4Ig, i.e., mouse CTLA4 and IgG2aFc, released from the CTLA4Ig transfected Mm1 cells, which was agreed with the findings by Lane et. al [12] .
CTLA4Ig from transfected Mm1 cells binds effectively to B7 molecules
It is reported that both B7-1 and B7-2 are the ligands for CTLA4 and expressed on cell surface as membrane antigens [8] [9] [10] [11] . CTLA4Ig binds these molecules with very high affinity [1] . To examine whether CTLA4Ig from E522.7.50 could bind the B-7 molecules, we performed indirect immunofluorescence staining of B7-1 and B7-2 transfectants with CTLA4Ig. Culture media from E522.7.50 cells was used as a source of CTLA4Ig, while in later experiments the purified protein was used. No difference was found between these two sources of CTLA4Ig (data not shown). Binding was detected by addition of culture media to B7-1 and B7-2 transfected cells and by subsequent addition of a second step reagent of FITC-conjugated goat anti-mouse Ig. Fig 2 showed the results of flow cytometry. B7-1 and B7-2 transfectants express a high level of mouse B7-1 and B7-2 on the cell surface respectively (Fig 2 A and C ). An increasing fluorescence intensity was found in culture media-treated groups, compared with that treated with PBS (Fig 2 B and D) . The cells were studied further by phase-contrast (Fig 3 a-d) and conventional immunofluorescence microscopy (Fig 3 A-D) . Simultaneously, results showed positively stained struc- Plasmid encoding a fusion protein of CTLA4Ig was transfected into Mm1 cells. After screening with ELISA, a high CTLA4Ig producing clone, E522.7.50, was selected. Culture media was collected and IgCg-containing proteins were purified by protein A affinity chromatography as described in materials and methods. Aliquots (2 μg) of protein A adherent fraction, mouse IgG1 and IgG2a were subjected to SDS-PAGE (12 % polyacrylamide) with or without prior reduction with 2ME. The proteins were stained by Coomassie Brilliant Blue (lanes 1-3) or transferred to a nitrocellulose membrane and stained with anti-Ig, anti-IgG2a ( γ2a chain) and anti-CTLA4 (lanes 4-15) antibodies, respectively. The positions of molecular weight markers are shown on the right of both panels. Note that CTLA4Ig from transfected Mm1 cells was specifically recognized by anti-Ig γ2a and anti-CTLA4 antibodies.
tures on the surface of B7-1 and B7-2 cells in culture media-treated group (Fig 3 B and D) , whereas the cells treated with PBS served as control were not stained or very weakly stained if any (Fig 3 A and C) . The staining was most prominent in the cell surface region and it could be seen more clearly by epifluorescence optical section images by confocal laser scanning microscopy (Fig 4 A) , suggesting that the CTLA4Ig could bind to mature B7-1 and B7-2 molecules that were expressed on the cell surface with higher affinity than that of immature forms of CTLA4Ig, that was usually found within the cells. These immunofluorescence findings indicated that CTLA4Ig from transfected Mm1 cells bound specifically to its ligands of B7-1 and B7-2 molecules and that the binding capability was confirmed to be high. 
CTLA4Ig from transfected Mm1 cells inhibits T-cell activation in mixed lymphocyte culture
In order to examine the biological activity of CTLA4Ig from transfected Mm1 cells, we then verified the biological ability of CTLA4Ig in terms of inhibitory effect on T-cell (Fig 3 B and D) , whereas the controls were not stained or very weakly stained if any (Fig 3 A and C) .
activation. Many studies have shown that the co-stimulatory signals through CD28 and/ or CTLA4 pathways are necessary for T-cell activation [1] [2] [3] . CTLA4Ig has been found to be able to block T-cell co-stimulation and allogeneic MLC when tested in vitro. BALB/c spleen cells were co-cultured with mitomycin C-treated C57BL/6 spleen cells in the medium containing CTLA4Ig from the transfected Mm1 cells. As shown in Fig 5, the spleen cells from BALB/c mice were activated when co-cultured with the spleen cells form C57BL/ 6 mouse and an isotope count of thymidine incorporated was 124836 5250 cpm. The spleen cell activation was completely inhibited by CTLA4Ig and the isotope count of thymidine incorporated was 83211 8604 cpm in the presence of CTLA4Ig. The difference between CTLA4Ig-treated and untreated groups was absolutely significant (p < 0. 005). The control experiments using responder and stimulator cells from same BALB/c mouse were 95452 7280 cpm. Thus, CTLA4Ig from the transfected Mm1 cells, E522.7. 50, seemed to be biologically active in inhibition of T-cell activation. The inhibition of MLC by CTLA4Ig from the transfected Mm1 cells resuted from the blockade of B7/CD28 co-stimulatory in T-cell.
Conclusions
To conclude, we have successfully introduced a murine CTLA4Ig gene into a macrophagic cell line Mm1 cells by the electroporation. CTLA4Ig from the transfected Mm1 cells could bind specifically to its ligands of B7 molecules and was biologically active. The expression of CTLA4Ig gene was stable and a high CTLA4Ig producing clone, E522.7.50, was obtained. The CTLA4Ig transfected Mm1 cells might be useful for the further biological and immunological studies in differentiation, maturation and functional activities of macrophages as well as investigation of CTLA4-related interactions of co-stimulation pathway in T-cell activation. Studies on therapeutic usage of the CTLA4Ig transfected Mm1 cells are ongoing and will be reported later. 
